We were pleased to announce the sale of our stake in Aptean.

Through our Flagship Fund strategy, we first formed Aptean through the merger of CDC and Consona in 2012. Thus began a tactical scaling of the business which included 17 add-on transactions and restructuring the company into a standalone ERP-centric business. Vista’s Foundation Fund acquired Aptean alongside TA Associates in 2019 and welcomed Charlesbank Capital Partners as an investment partner in 2020. Since then, Aptean’s management team has executed a robust M&A strategy, completing more than 30 acquisitions, representing approximately $1 billion in total enterprise value.

Additionally, the team accelerated growth via go-to-market upscaling and refinements. With support from Vista’s Value Creation Team and engine, Aptean launched strategic initiatives to position the business for scale – building out the executive leadership team, investing in the development of the next level of senior managers and improving operational efficiencies across the organization.

This exit – along with other recent exits for SecureLink, Datto, iCIMS (partial) and Ping (pending) – is a testament to the power of our ecosystem of knowledge, resources and relationships, and our ability to leverage that ecosystem to create value for our companies and our Limited Partners.

It has been a pleasure partnering with the entire Aptean team, and we wish them the best as they embark on this next chapter.